
BioCryst Pharmaceuticals Inc
BCRXNASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$9.05
Day High
$9.10
Day Low
$8.82
Prev. Close
$9.10
VolumeShares traded today.
3.07M
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$2.27B
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-5.02
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$11.31
52W LowLowest price over the past 52 weeks.
$6.00
50D MAAverage closing price over the last 50 trading days.
$9.18
200D MAAverage closing price over the last 200 trading days.
$7.92
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+6.5%1M
-0.9%6M
+30.1%YTD
+18.8%1Y
-17.0%About
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir (Rapivab) was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China.
www.biocryst.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade BCRX
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.